[1] |
石卫东,何春年,陈堔,等.肠病相关性T细胞淋巴瘤2例报告[J].诊断病理学杂志,2006,10(13):377-379.
|
[2] |
吴斌,温文,何怀纯,等.原发性大肠恶性淋巴瘤临床、内镜与病理特点[J].中华消化内镜杂志,2000,17(1):11-14.
|
[3] |
Swerdlow SH,Campo E,Harris NL,et al.WHO classification of tumours of haematopoielic and lymphoid tissues[M].Lyon:ⅠARC,2008:285-288.
|
[4] |
Di Sabatino A,Biagi F,Gobbi PG,et al.HowⅠtreat enteropathy-associated T-cell lymphoma[J].Blood,2012,119(11):2458-2468.
|
[5] |
Ko YH,Karnan S,Kim KM,et al.Enteropathy-associated T-cell lymphoma-a clinicopathologic and array comparative genomichybridization study[J].Hum Pathol,2010,41(9):1231-1237.
|
[6] |
Swerdlow SH,Campo E,Pileri SA,et al.The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J].Blood,2016,127(20):2375-2390.
|
[8] |
刘思德,姜泊,周殿元,等.肠病型T细胞淋巴瘤内镜典型形态——附6例临床分析[J].现代消化及介入诊疗,2004,9(2):114-118.
|
[9] |
梅刚,林汉良.淋巴瘤病理诊断图谱[M].广州:广东科技出版社,2010:129-131.
|
[10] |
官兵,周晓军.淋巴瘤病理诊断常用免疫组化抗体的选择策略[J].临床与实验病理学杂志,2011,27(1):1-9.
|
[11] |
达娃卓玛,高子芬,林梦,等.肠病相关T细胞淋巴瘤21例临床病理特征分析[J].肿瘤研究与临床,2016,28(5):300-303.
|
[7] |
Kikuma K,Yamada K,Nakamura S,et al.Detailed clinicopathological characteristics and possible lymphomagenesis of typeⅠⅠintestinal enteropathy-associated T-cell lymphoma in Japan[J].Hum Pathol,2014,45(6):1276-1284.
|
[12] |
周鸿,季福,李可为.小肠肠病型T细胞淋巴瘤诊治(附3例报告)[J].外科理论与实践,2005,10(2):176-177.
|
[13] |
Bishton MJ,Haynes AP.Combination chemotherapy followed by autologoustem cell transplant for enteropathy-associated T cell lymphoma[J].Br J Haematol,2007,136(1):111-113.
|
[14] |
张文燕,李甘地,刘卫平,等.肠道T细胞淋巴瘤的预后分析[J].中华病理学杂志,2002,31(4):295-299.
|
[15] |
李小秋,李甘地,高子芬,等.中国淋巴瘤亚型分布:圈内多中心性病例10002例分析[J].诊断学理论与实践,2012,11(2):111-115.
|